Newsroom

NEW YORK & DUBLIN & TOKIO--(BUSINESS WIRE)--Sumitomo Corporation, SMBC Aviation Capital, door Apollo beheerde fondsen ("Apollo") en Brookfield hebben vandaag bekendgemaakt dat zij de eerder aangekondigde overname van Air Lease Corporation ("Air Lease") hebben afgerond en dat zij de onderneming hebben omgedoopt tot Sumisho Air Lease Corporation ("Sumisho Air Lease"). Deze ingrijpende transactie versterkt de financiële positie van het bedrijf dankzij de langetermijnsteun en luchtvaartkennis van m...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Upstart Holdings, Inc. (“Upstart” or the “Company”) (NASDAQ:UPST) securities during the period of May 14, 2025 through November 4, 2025, inclusive (“the Class Period”).If you suffered a loss on your Upstart investments, you have until June 8, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted...

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until May 26, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadlin...

GRAND CAYMAN, Cayman Islands--(BUSINESS WIRE)--Nu Holdings Ltd. ("Nu" or the "Company") (NYSE: NU) hereby informs its shareholders and the market that it has filed today, April 8, its Annual Report on Form 20-F (“Form 20-F”) with the U.S. Securities and Exchange Commission ("SEC"). This document refers to the fiscal year ended December 31, 2025. The documents have been posted on our Investor Relations website: https://www.investidores.nu/en/ Company shareholders may receive a hard copy of the F...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Millennium Group International Holdings Limited (NASDAQ: MGIH) resulting from allegations that Millennium Group may have issued materially misleading business information to the investing public.So what: If you purchased Millennium Group securities you may be entitled to compensation without payment of any out of pocket fees or...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against OneMain Holdings, Inc. (“OneMain” or the “Company”) (NYSE:OMF). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On March 16, 2026, New York Attorney General Letitia James, along with a coalition of 12 other state att...

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Eos Energy Enterprises, Inc. (“Eos Energy” or the “Company”) (NASDAQ:EOSE) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until May 5, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after thi...

TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total brut (1) Total net (2) 31 mars 2026 35 511 655 45 299 226 44 075 154 (1)   Le nombre de droits de vote bruts (ou droits de vote “théoriques”) sert de base de calcul pour les franchissements de seuil. Conformément à l’article 223-11 du Règlement Gé...

TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (Paris:ABNX): Market: Euronext Paris, Compartment C ISIN code: FR0012616852 Date Number of shares outstanding Total voting rights Total gross (1) Total net (2) March 31, 2026 35,511,655 45,299,226 44,075,154 (1)   The total number of gross (or “theoretical”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the ba...

BEAVERTON, Oregon--(BUSINESS WIRE)--Gurobi Optimization, LLC, der Marktführer im Bereich Decision-Intelligence-Technologie, verkündete heute eine erneuerte Markenidentität, die seine Rolle bei der Unterstützung von Unternehmen widerspiegelt, in komplexen, risikoreichen Umgebungen bessere Entscheidungen zu treffen. Organisationen setzen zunehmend auf Optimierung, um ihre KI-gestützten Erkenntnisse umzusetzen. In diesem Kontext ist der Gurobi Optimizer eine wesentliche Komponente von Decision-Int...